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Do Patients With Irritable Bowel Syndrome 
Exhale More Hydrogen Than Healthy Subjects 
in Fasting State?
TO THE EDITOR: Irritable bowel syndrome (IBS) is a com-
mon disorder characterized by persistent or recurrent abdominal 
pain and discomfort with altered bowel habits. It affects approx-
imately 10%-20% of the adult population, with typical symptoms 
like abdominal pain, constipation, diarrhea and bloating.
1,2 Al-
though IBS is not lethal, it can reduce quality of life and increase 
medical costs. While the cause of IBS is still unclear, visceral hy-
persensitivity, immune activation, enteric neuromuscular dys-
function and dysfunction of the brain-gut axis have been sug-
gested.
3-6 Small intestinal bacterial overgrowth (SIBO) has also 
been proposed as an etiologic factor in IBS, but the evidence is 
conflicting yet.
7
With great interest, I read the report by Kumar et al
8 regard-
ing the increased fasting breath hydrogen levels among patients 
with IBS as compared with healthy controls (HC). Kumar et al
8 
suggested that average fasting breath hydrogen was higher in pa-
tients with IBS as compared to HC (mean 10.1 ± 6.5 vs 5.5 ± 
6.2 ppm, p ＜ 0.001) and number of stools per week correlated 
with average fasting breath hydrogen excretion in patients with 
IBS (r = 0.26, p = 0.02). The fasting breath hydrogen level was 
not different between patients with diarrhea predominant IBS 
(D-IBS) and constipation predominant IBS (C-IBS) (either by 
subjective feeling or by Bristol Stool Form Scale). 
Although the authors showed a clear result of different fast-
ing breath hydrogen levels between IBS and HC, some doubt 
was raised because it is inconsistent with the previous results of 
same study group. Breath hydrogen levels were similar between 
IBS excluding D-IBS and HC, whatever fasting or following 
glucose ingestion, and the breath hydrogen levels following glu-
cose ingestion were higher in chronic non-specific diarrhea in-
cluding D-IBS than other types of IBS and HC according to the 
previous report.
9 I wonder why the fasting breath hydrogen le-
vels were not different between D-IBS and C-IBS in the present 
study. I think that the result might have changed if the authors 
classified the IBS subtypes by Rome III criteria.
10 I also wonder 
about the frequency of C-IBS subtype which was higher than 
D-IBS, when 77 of 81 IBS patients (95.1%) complained loose 
stool at the onset of pain.
8
In the previous studies, fasting breath hydrogen levels were 
not different among patients with IBS and controls, contrary to 
the result from the present study.
11-13 Even the breath hydrogen 
levels following lactulose ingestion were comparable between IBS 
and controls.
11 Although the authors suggested that this contra-
dictory result might be related to non-comparable IBS and con-
trol group and bias in selection of IBS patients, there are still 
doubtful points and the result needs to be validated by larger 
scaled study. 
The authors suggested that fasting breath hydrogen levels 
might correlate with diarrhea because the stool frequency per 
week correlated with fasting breath hydrogen level, albeit weakly.
8 
However, IBS patients with incomplete evacuation might visit 
toilet repeatedly resulting in spuriously increased stool frequency 
as the authors mentioned in the discussion. So, Bristol Stool 
Form Scale might be meaningful rather than the stool frequency 
for estimating the relationship between fasting breath hydrogen 
levels and diarrhea.
14 The authors did not show the correlation 
between fasting breath hydrogen levels and Bristol Stool Form 
Scale of IBS patients. Besides, the authors hypothesized that 
bloating might have originated from increased hydrogen gas in 
IBS, but did not estimate the correlation between bloating se-
verity and fasting breath hydrogen levels. I think that these addi-
tional data can make the present study more valuable. 
Despite several limitations of the present study, it provides us 
with the important clues in understanding the pathophysiological 
mechanisms of bloating and diarrhea in IBS patients. Further 
large scaled studies are needed to validate the results of the pres-Letters to the Editor 
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ent study and to clarify the role of hydrogen gas and SIBO in 
IBS.
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